Market Tracker

06/24 5:16pm ET

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

0.6326
Delayed Data
As of 4:00pm ET
 -0.0546 / -7.95%
Today’s Change
0.57
Today|||52-Week Range
12.55
-80.23%
Year-to-Date

Today’s Trading

Previous close0.69
Today’s open0.64
Day’s range0.57 - 0.69
Volume5,552,730
Average volume (3 months)608,106
Market cap$69.9M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)+35.37%
Earnings growth (this year)--
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+19.60%
P/E ratioNM
Price/Sales143.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LIFEaTyr Pharma Inc-0.08-2.72%
ZYNEZynerba Pharmaceutic...-0.12-1.54%
XOMAXOMA Corp-0.04-7.90%
DRNADicerna Pharmaceutic...-0.13-3.95%
Data as of 4:00pm ET, 06/24/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$1.7M
Annual profit (last year)-$114.7M
Net profit margin-6,598.10%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO, CFO &
CAO
Linda F. Powers
Chief Scientific Officer &
Secretary
Alton L. Boynton
Corporate headquarters
Bethesda, Maryland

Forecasts